Pivoting from the production of personal protective equipment, Stratasys ( SSYS -1.53% ) announced today that it's focusing on another critical aspect of the COVID-19 outbreak: testing. To help alleviate supply shortages, Stratasys announced that it is partnering with Origin, which is also focused on additive manufacturing, to help deliver nasopharyngeal (NP) swabs to healthcare workers and medical centers across the United States. According to the agreement, Stratasys will market and promote Origin's 3D-printed NP swabs as Origin strives to ramp up production of the swabs to 1.3 million per week.